Skip to main content
Book cover

Dermatomyositis pp 111–121Cite as

Internal Malignancy Associated with Dermatomyositis

  • Chapter

  • 1578 Accesses

Although all the inflammatory myopathies can have a coincidental association with malignant disease, especially in older age-groups, the frequency of cancer is definitely increased in DM [1]. DM is an idiopathic inflammatory myopathy with diagnostic cutaneous manifestations, which often heralds paraneoplastic features of underlying internal malignancy [2].

Keywords

  • Inclusion Body Myositis
  • Inflammatory Myopathy
  • Idiopathic Inflammatory Myopathy
  • Occult Malignancy
  • Myositis Patient

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-540-79313-7_18
  • Chapter length: 11 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   119.00
Price excludes VAT (USA)
  • ISBN: 978-3-540-79313-7
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   149.00
Price excludes VAT (USA)
Hardcover Book
USD   179.99
Price excludes VAT (USA)
Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sigurgeirsson B, Lindelöf B, Edhag O, Allander E. Risk of cancer in patients with dermato-myositis or polymyositis: a population-based study.N Engl J Med1992; 326: 363–367.

    PubMed  CAS  Google Scholar 

  2. Drake L, Dinehart SM, Farmer ER, et al. Guidelines of care for dermatomyositis.J Am Acad Dermatol1996; 34: 824–829.

    CrossRef  PubMed  CAS  Google Scholar 

  3. Stertz G. Polymyositis.Berl Klin Wochenschr1916; 53: 489.

    Google Scholar 

  4. Kankeleit H. Uber primaire nichteitrige polymyositis.Dtsch Arch Klin Med1916; 120: 335–339.

    Google Scholar 

  5. Richardson J, Callen J. Dermatomyositis and malignancy.Med Clin North Am1989; 73: 1211–1220.

    PubMed  CAS  Google Scholar 

  6. Barnes BE, Mawr B. Dermatomyositis and malignancy. A review of the literature.Ann Intern Med1976; 84: 68–76.

    PubMed  CAS  Google Scholar 

  7. Schuerman H. Zür Klinik und Pathogenese der Dermatomyositis [Polymyositis].Arch Derma-tol Syph1939; 178: 414–468.

    CrossRef  Google Scholar 

  8. Curtis AC, Blaylock HC, Harell ER. Malignant lesions associated with dermatomyositis.JAMA1952; 150(9): 844–846.

    CAS  Google Scholar 

  9. Christianson HB, Brunsting LA, Perry HO. Dermatomyositis: unusual features, complications and treatment.Arch Dermatol1954; 74: 581–589.

    Google Scholar 

  10. Arundell FD, Wilkinson RD, Haserick JR. Dermatomyositis and malignant neoplasm in adults: an survey of twenty years' experience.Arch Dermatol1960; 82: 772–775.

    PubMed  CAS  Google Scholar 

  11. Batschwarov B, Minkov D. Dermatomyositis and carcinoma. (A study based on an 18 years follow-up in Bulgaria).Br J Dermatol1968; 80: 84–85.

    CrossRef  Google Scholar 

  12. Bohan A, Peter JB, Bowman RL, et al. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis.Medicine1977; 56: 255–286.

    CrossRef  PubMed  CAS  Google Scholar 

  13. Bernard P, Bonnetblanc JM. Dermatomyositis and malignancy.J Invest Dermatol1993; 100(1): 128S–132S.

    CrossRef  PubMed  CAS  Google Scholar 

  14. Callen J P, Hyla J F, Bole GG Jr, et al. The relationship of dermatomyositis and polymyositis to internal malignancy.Arch Dermatol1980; 116(3): 295–298.

    CrossRef  PubMed  CAS  Google Scholar 

  15. Manchul L, Jin A, Pritchard KI, et al. The frequency of malignancy in patients with dermato-myositis/polymyositis.Arch Intern Med1985; 145: 1835–1839.

    CrossRef  PubMed  CAS  Google Scholar 

  16. Hidano A, Kaneko K, Arai Y, et al. Survey of the prognosis for dermatomyositis, with special reference to its association with malignancy and pulmonary fibrosis.J Dermatol1986; 13(4): 233–241.

    PubMed  CAS  Google Scholar 

  17. Lakhanpal S, Bunch T W, Ilstrup DM, et al. Polymyositis-dermatomyositis and malignant lesions: Does an association exist?Mayo Clin Proc1986; 61: 645–653.

    PubMed  CAS  Google Scholar 

  18. Chen YJ, Wu C Y, Shen JL. Predicting factors of malignancy in dermatomyositis and polymy-ositis: a case-control study.Br J Dermatol2001; 144: 825–831.

    CrossRef  PubMed  CAS  Google Scholar 

  19. Stockton D, Doherty VR, Brewster DH. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study.Br J Cancer2001; 85: 41–45.

    CrossRef  PubMed  CAS  Google Scholar 

  20. Airio A, Pukkala E, Isomäki H. Elevated cancer incidence in patients with dermatomyositis: a population-based study.J Rheumatol1995; 22: 1300–1303.

    PubMed  CAS  Google Scholar 

  21. Yazici Y, Kagen LJ. The association of malignancy with myositis.Curr Opin Rheumatol2000; 12(6): 498–500.

    CrossRef  PubMed  CAS  Google Scholar 

  22. Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyosi-tis and polymyositis: a population-based study.Lancet2001; 357: 96–100.

    CrossRef  PubMed  CAS  Google Scholar 

  23. Buchbinder R, Forbes A, Hall S, et al. Incidence of malignant disease in biopsy-proven inflammatory myopathy.Ann Intern Med2001; 134: 1087–1095.

    PubMed  CAS  Google Scholar 

  24. Chow WH, Gridley G, Mellemkjaer L, et al. Cancer risk following polymyositis and dermato-myositis: a nationwide cohort study in Denmark.Cancer Causes Control1995; 6: 9–13.

    CrossRef  PubMed  CAS  Google Scholar 

  25. Dorph C, Lundberg IE. Idiopathic inflammatory myopathies — myositis.Best Pract Res Clin Rheumatol2002; 16(5): 817–832.

    CrossRef  PubMed  Google Scholar 

  26. Zantos D, Zhang Y, Felson D. The overall and temporal association of cancer with polymyosi-tis and dermatomyositis.J Rheumatol1994; 21(10): 1855–1859.

    PubMed  CAS  Google Scholar 

  27. Rose C, Hatron P Y, Brouillard M, et al. Signes prédicatifs de cancers au cours de la dermato-myosite. Etude de 29 observations.Rev Med Int1994; 15(1): 19–24.

    CrossRef  CAS  Google Scholar 

  28. Leow YH, Goh CL. Malignancy and adult dermatomyositis.Int J Dermatol1997; 36: 904–907.

    CrossRef  PubMed  CAS  Google Scholar 

  29. Dourmishev LA. Dermatomyositis associated with malignancy. 12 case reports.Adv Exp Med Biol1999; 455: 193–199.

    PubMed  CAS  Google Scholar 

  30. Sherry DD, Haas JE, Milstein JM. Childhood polymyositis as a paraneoplastic phenomenon.Pediatr Neurol1993; 9: 155–156.

    CrossRef  PubMed  CAS  Google Scholar 

  31. Léaute-Labrèze C, Perel Y, Taïeb A. Childhood dermatomyositis associated with hepatocarci-noma.N Engl J Med1995; 333(16): 1083.

    CrossRef  PubMed  Google Scholar 

  32. Jansen ML, Weiting JM, Andary MT, et al. Inclusion body myositis and transitional cell carcinoma of the bladder: significant resolution of symptoms after tumour excision.Arch Phys Med Rehabl1997; 78: 237–239.

    CrossRef  Google Scholar 

  33. Hatada T, Aoki I, Ikeda H, et al. Dermatomyositis and malignancy: case report and review of the Japanese literature.Tumori1996; 82: 273–275.

    PubMed  CAS  Google Scholar 

  34. Verducci MA, Malkasian GD, Friedman SJ, et al. Gynecologic carcinoma associated with dermatomyositis—polymyositis.Obstret Gyncol1984; 64: 695.

    CAS  Google Scholar 

  35. Callen J P. Dermatomyositis and female malignancy.J Surg Oncol1986; 32: 121–124.

    CrossRef  PubMed  CAS  Google Scholar 

  36. Mordel N, Margalioth EJ, Harats N, et al. Concurrence of ovarian cancer and dermatomyosi-tis. A report of two cases and literature review.J Reprod Med1988; 33(7): 649–655.

    PubMed  CAS  Google Scholar 

  37. Cherin P, Piette JC, Herson S, et al. Dermatomyositis and ovarian cancer: a report of 7 cases and literature review.J Rheumatol1993; 20: 1897–1899.

    PubMed  CAS  Google Scholar 

  38. Kubo M, Sato S, Kitahara H, et al. Vesicle formation in dermatomyositis associated with gynecologic malignancies.J Am Acad Dermatol1996; 34: 391–394.

    CrossRef  PubMed  CAS  Google Scholar 

  39. Davis MD, Ahmed I. Ovarian malignancy in patients with dermatomyositis and polymyositis: a retrospective analysis of fourteen cases.J Am Acad Dermatol1997; 37: 730–733.

    CrossRef  PubMed  CAS  Google Scholar 

  40. Tymms KE, Webb J. Dermatomyositis and other connective tissue diseases: a review of 105 cases.J Rheumatol1985; 12: 1140–1148.

    PubMed  CAS  Google Scholar 

  41. Sekine H, Ohya K, Kojima S, et al. Dermatomyositis associated with urachal adenocarcinoma.J Urology2002; 168: 1488–1489.

    CrossRef  Google Scholar 

  42. Smith CJ, Staniland JR. A difficult case of inflammatory myositis.Age Ageing2003; 32: 351–352.

    CrossRef  PubMed  Google Scholar 

  43. Lingor P, von Boetticher D, Bahr M, et al. Paraneoplastic polymyositis in recurring adrenal gland carcinoma.Lancet Neurology2003; 2: 435–436.

    CrossRef  PubMed  Google Scholar 

  44. Chan HL. Dermatomyositis and cancer in Singapoore.Int J Dermatol1985; 24: 447–450.

    PubMed  CAS  Google Scholar 

  45. Fung WK, Chan HL, Lam WM. Amyopathic dermatomyositis in Hong Kong — association with nasopharyngeal carcinoma.Int J Dermatol1998; 37: 659–663.

    CrossRef  PubMed  CAS  Google Scholar 

  46. Wong KO. Dermatomyositis: a clinical investigation of 23 cases in Hong Kong.Br J Dermatol1969; 81: 544–547.

    CrossRef  PubMed  CAS  Google Scholar 

  47. Cheng TI, Tsou MH, Yang PS, et al. Dermatomyositis and erythrocytosis associated with hepatocellular carcinoma.J Gastroenterol Hepatol2002; 17: 1239–1242.

    CrossRef  PubMed  Google Scholar 

  48. Dourmishev LA, Dourmishev AL, Schwartz RA. Dermatomyositis: cutaneous manifestations of its variants.Int J Dermatol2002; 41(10): 625–630.

    CrossRef  PubMed  Google Scholar 

  49. Callen J P. Dermatomyositis.Neurol Clin1987; 5: 379–403.

    PubMed  CAS  Google Scholar 

  50. Stonecipher MR, Jorizzo JR, White WL, et al. Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: Dermatomyositis sine myositis?J Am Acad Dermatol1993; 28: 951–956.

    CrossRef  PubMed  CAS  Google Scholar 

  51. Stonecipher MR, Jorizzo JR, Monu J, et al. Dermatomyositis with normal muscle enzyme concentration. A single-blind study of the diagnostic value of magnetic resonance imaging and ultrasound.Arch Dermatol1994; 130: 1294–1299.

    CrossRef  PubMed  CAS  Google Scholar 

  52. Whitmore S, Anhalt G, Provost T, et al. Serum CA-125 screening for ovarian cancer in patients with dermatomyositis.Gynecol Oncol1997; 65: 241–244.

    CrossRef  PubMed  CAS  Google Scholar 

  53. Finger DR, Dunn CL, Gilliland WR, et al. Amyopathic dermatomyositis associated with malignancy.Int J Dermatol1996; 35: 663–664.

    CrossRef  PubMed  CAS  Google Scholar 

  54. Osman Y, Narita M, Kishi K, et al. Case report: amyopathic dermatomyositis associated with transformed malignant lymphoma.Am J Med Sci1996; 311: 240–242.

    CrossRef  PubMed  CAS  Google Scholar 

  55. Russ B W, English JC, King DH, et al. Amyopathic dermatomyositis associated with transitional cell carcinoma of the bladder.Cutis1999; 63: 73–76.

    PubMed  CAS  Google Scholar 

  56. Kagen LJ. Amyopathic dermatomyositis.Arch Dermatol1995; 131: 1458–1459.

    CrossRef  PubMed  CAS  Google Scholar 

  57. Sontheimer RD. Dermatomyositis: an overview of recent progress with emphasasis on derma-tologic aspects.Dermatol Clin2002; 20: 387–408.

    CrossRef  PubMed  Google Scholar 

  58. el-Azhary R, Pakzad SY. Amyopathic dermatomyositis: retrospective review of 37 cases.J Am Acad Dermatol2002; 46: 560–565.

    CrossRef  PubMed  Google Scholar 

  59. Ang P, Sugeng M W, Chua SH. Classic and amyopathic dermatomyositis seen at the National Skin Centre of Singapore: a 3-year retrospective review of their clinical characteristics and association with malignancy.Ann Acad Med Singapore2000; 29: 219–223.

    PubMed  CAS  Google Scholar 

  60. Taieb A, Guichard C, Salamon R, et al. Prognosis in juvenile dermatopolymyositis: a cooperative retrospective study of 70 cases.Pediatr Dermatol1985; 2: 275–281.

    CrossRef  PubMed  CAS  Google Scholar 

  61. Falcini F, Taccetti G, Trapani S, et al. Acute lymphoblastic leukemia associated with dermato-myositis in a child.Pediatr Dermatol1993; 10: 199–200.

    CrossRef  Google Scholar 

  62. Kalmanti M, Athanasiou A. Neuroblastoma occurring in a child with dermatomyositis.Am J Pediatr Hematol Oncol1985; 7: 387–388.

    PubMed  CAS  Google Scholar 

  63. De Bersques J. Deux cas de dermatomyosite chez des adolescentes.Nouv Dermatol1987; 6: 499.

    Google Scholar 

  64. Leaute-Labreze C, Perel Y, Taieb A. Childhood dermatomyositis associated with hepatocarci-noma.N Engl J Med1995; 333: 1083–1084.

    CrossRef  PubMed  CAS  Google Scholar 

  65. Dourmishev A, Dourmishev L. Dermatomyositis and drugs.Adv Exp Med Biol1999; 455: 187–191.

    PubMed  CAS  Google Scholar 

  66. Rocamora V, Puig L, Alomar A. Dermatomyositis-like eruption following hydroxyurea therapy.J Eur Acad Dermatol Venereol2000; 14: 227–228.

    CrossRef  PubMed  CAS  Google Scholar 

  67. Marie I, Joly P, Levesque H, et al. Pseudo-dermatomositis as a complication of hydroxyurea therapy.Clin Exp Rheumatol2000; 18: 536–537.

    PubMed  CAS  Google Scholar 

  68. Ruiz-Genao D P, Sanz-Sánchez T, Bartolomé-González B, et al. Dermatomyositis-like reaction induced by chemotherapeutical agents.Int J Dermatol2002; 41: 885–887.

    CrossRef  PubMed  CAS  Google Scholar 

  69. Harris AL, Smith IE, Snaith M. Tamoxifen-induced tumor regression associated with dermatomyositis.Br Med J1982; 284: 1674.

    CrossRef  CAS  Google Scholar 

  70. Akiyama C. Osada A, Sou K, et al. A case of dermatomyositis triggered by tegafur.Acta Derm Venereol (Stockh)1997; 77: 490.

    Google Scholar 

  71. Monk BE, Pembroke AC. Dermatomyositis following radiotherapy.Br J Dermatol1983; 109 (Suppl 24): 103.

    Google Scholar 

  72. Richard M, Truchetet F, Friedel J, et al. Skin lesions simulating chronic dermatomyositis during long-term hydroxyurea therapy.J Am Acad Dermatol1989; 21: 797–799.

    CrossRef  PubMed  CAS  Google Scholar 

  73. Krishnan K, Adams P, Silveira S, et al. Therapy-related acute myeloid leukaemia following immunosuppression with azathioprine for polymyositis.Clin Lab Haematol1994; 16: 285–289.

    CrossRef  PubMed  CAS  Google Scholar 

  74. Arnold JA, Ranson SA, Abdalla SH. Azathioprine-associated acute myeloid leukaemia with trilineage dysplasia and complex karyotype: a case report and review of the literature.Clin Lab Haematol1999; 21(4): 289–292.

    CrossRef  PubMed  CAS  Google Scholar 

  75. Roddy E, Courtney PA, Morris A. Non-Hodgkin's lymphoma in a patient with refractory dermatomyositis which had been treated with infliximab.Rheumatology(Oxford) 2002; 41(10): 1194–1195.

    CrossRef  PubMed  CAS  Google Scholar 

  76. Talanin N Y, Bushore D, Rasberry R, et al. Dermatomyositis with the features of inclusion body myositis associated with carcinoma of the bladder.Br J Dermatol1999; 141: 926–930.

    CrossRef  PubMed  CAS  Google Scholar 

  77. Goh CL, Rajan VS. Dermatomyositis in a skin centre.Ann Acad Med Singapore1983; 12: 6–12.

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and Permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2009). Internal Malignancy Associated with Dermatomyositis. In: Dermatomyositis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79313-7_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-79313-7_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-79312-0

  • Online ISBN: 978-3-540-79313-7

  • eBook Packages: MedicineMedicine (R0)